[go: up one dir, main page]

ALTER et al., 2004 - Google Patents

FINAL ACCEPTED VERSION

ALTER et al., 2004

Document ID
6122509217553527945
Author
ALTER P
CAT C
Publication year

External Links

Snippet

Cytokines represent a complex group of secreted molecules involved in most aspects of inflammation in all organs and systems, including intestinal inflammation (46, 52). A number of properties are attributed to these proteins, which mediate stimulatory or inhibitory signals …
Continue reading at journals.physiology.org (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application

Similar Documents

Publication Publication Date Title
Cao et al. Proinflammatory cytokines alter/reduce esophageal circular muscle contraction in experimental cat esophagitis
Rott et al. Phosphodiesterase inhibitor pentoxifylline, a selective suppressor of T helper type 1‐but not type 2‐associated lymphokine production, prevents induction of experimental autoimmune encephalomyelitis in Lewis rats
JP2005506320A (en) Hydroxamic acid derivatives that inhibit the histone deacetylase enzyme as anti-inflammatory agents that inhibit new cytokine synthesis
Lance et al. A physiological approach to clinical neurology
Fantuzzi et al. IL-12–induced IFN-γ is dependent on caspase-1 processing of the IL-18 precursor
Orban et al. Caffeic acid phenethyl ester induces leukocyte apoptosis, modulates nuclear factor-kappa B and suppresses acute inflammation
De Simoni et al. Inflammatory cytokines and related genes are induced in the rat hippocampus by limbic status epilepticus
Bai et al. The effect of the cholinergic anti‐inflammatory pathway on experimental colitis
CN102458476B (en) Compositions and methods for treating multiple sclerosis
Kinoshita et al. Role of TNF‐α in muscularis inflammation and motility disorder in a TNBS‐induced colitis model: clues from TNF‐α‐deficient mice
Hermann et al. TNF α: A trigger of autonomic dysfunction
Kazumori et al. Neutrophil chemoattractant 2β regulates expression of the Reg gene in injured gastric mucosa in rats
Song et al. IL-4–induced activation of the Stat6 pathway contributes to the suppression of cell-mediated immunity and death in sepsis
Molenaar et al. Distribution of interleukin 1β immunoreactivity within the porcine hypothalamus
WO1999066037A2 (en) Antisense oligonucleotides for treating or preventing atopic diseases and neoplastic cell proliferation
De Groat et al. Enkephalinergic inhibition in parasympathetic ganglia of the urinary bladder of the cat.
Brück et al. TNF-α suppresses CR3-mediated myelin removal by macrophages
Roda et al. Effects of anesthetics on hypoglossal nerve discharge and c‐Fos expression in brainstem hypoglossal premotor neurons
Torrents et al. Antinerve growth factor treatment prevents intestinal dysmotility in Trichinella spiralis-infected rats
Toth et al. Tumorigenic effect of 4-methylphenylhydrazine hydrochloride in Swiss mice
ALTER et al. FINAL ACCEPTED VERSION
Shore et al. Enhanced airway responses to substance P after repeated challenge in guinea pigs
Pierrefiche et al. Synaptic potentials in respiratory neurones during evoked phase switching after NMDA receptor blockade in the cat
Kinscherf et al. Effect of alterations of blood cholesterol levels on macrophages in the myocardium of New Zealand White rabbits
Watanabe et al. Effect of a benzylidene derivative, a novel antirheumatic agent, on IL-1 production